compound 23
oral interleukin 17A modulator favorable in vivo PK profile in multiple species from a previous patent and SBDD J. Med. Chem. LEO Pharma Research & Early Development, Ballerup, DK
Molecules of the Month - June 2022
5 minute read
Jul. 27, 2022
“Compound 23” (LEO Pharma) is an Oral IL-17A Protein−Protein Interaction Modulator